Comparing daytime pharmacokinetic and pharmacodynamic profiles of once-daily lisdexamfetamine versus twice-daily dexamfetamine in adult ADHD
Dexamfetamine (DEX) and lisdexamfetamine (LDX) are both prescribed to treat adult ADHD in the Netherlands. LDX is marketed as a long-acting prodrug of DEX requiring once-daily dosing, unlike DEX, which…
Suggested reading